The quarter's negative performance stands in stark contrast to the company's previous trajectory. Net sales turned negative at ₹-0.10 crores, plunging 108.70% quarter-on-quarter from ₹1.15 crores in Q3 FY26, whilst the year-on-year comparison shows a 113.51% decline from ₹0.74 crores in Q4 FY25. Operating profit before depreciation, interest and tax (PBDIT) excluding other income deteriorated to ₹-0.22 crores, the lowest level recorded in recent quarters, with the operating margin swinging to an alarming 220.00% negative territory.
Financial Performance: Troubling Deterioration Across Metrics
The quarterly financials reveal a company grappling with fundamental operational challenges. Revenue generation has collapsed, with net sales turning negative for the first time in the observed period. The sequential decline from ₹1.15 crores in Q3 FY26 to ₹-0.10 crores in Q4 FY26 represents a complete breakdown in the company's core lending and investment activities. Year-on-year comparisons paint an equally concerning picture, with the ₹0.74 crores recorded in Q4 FY25 now replaced by negative revenues.
| Quarter | Net Sales (₹ Cr) | QoQ Change | Net Profit (₹ Cr) | QoQ Change | PAT Margin % |
|---|---|---|---|---|---|
| Mar'26 | -0.10 | ▼ 108.70% | -0.49 | ▼ 194.23% | 490.00% |
| Dec'25 | 1.15 | ▲ 64.29% | 0.52 | ▲ 136.36% | 45.22% |
| Sep'25 | 0.70 | ▲ 45.83% | 0.22 | ▲ 1200.00% | 31.43% |
| Jun'25 | 0.48 | ▼ 35.14% | -0.02 | ▼ 101.90% | -4.17% |
| Mar'25 | 0.74 | ▲ 469.23% | 1.05 | ▲ 400.00% | 141.89% |
| Dec'24 | 0.13 | ▼ 51.85% | -0.35 | ▼ 84.21% | -269.23% |
| Sep'24 | 0.27 | — | -0.19 | — | -70.37% |
Interest expenses remained stubbornly elevated at ₹0.26 crores in Q4 FY26, virtually unchanged from the previous quarter's ₹0.27 crores. However, with negative revenue generation, this interest burden has become unsustainable, directly contributing to the pre-tax loss of ₹0.49 crores. The company reported zero tax liability for the quarter, consistent with its loss-making status. Notably, the company has not reported any tax payments across all observed quarters, raising questions about accumulated losses and carry-forward provisions.
Operational Challenges: Weak Capital Efficiency and Profitability
The company's operational metrics reveal fundamental weaknesses in capital deployment and return generation. Return on equity (ROE) averaged just 2.42% over the long term, significantly below the peer group average and indicative of poor capital efficiency. The latest quarterly ROE of 23.79% appears artificially inflated due to the extremely small equity base and volatile quarterly earnings, making it an unreliable indicator of sustainable profitability. Higher ROE typically signals better capital efficiency and profitability, but in Shyamkamal's case, the metric's volatility undermines its credibility as a quality indicator.
Return on capital employed (ROCE) stood at 7.52% as of the latest available data, reflecting modest returns on the capital deployed in the business. For an NBFC operating in a competitive lending environment, this level of ROCE suggests limited pricing power and potentially sub-optimal asset allocation. The company's balance sheet shows shareholder funds of ₹7.51 crores as of March 2025, up from ₹3.63 crores in March 2024, primarily driven by a ₹3.36 crores increase in share capital to ₹13.50 crores. However, reserves and surplus remain negative at ₹-5.99 crores, highlighting accumulated losses over time.
Critical Concern: Negative Revenue Generation
The most alarming aspect of Q4 FY26 results is the negative net sales of ₹0.10 crores. For an NBFC, negative revenue typically indicates write-offs, provisioning charges, or reversal of previously recognised income exceeding fresh income generation. This signals potential asset quality deterioration and raises serious questions about the sustainability of the business model. With interest costs remaining fixed at ₹0.26 crores whilst revenues turn negative, the company faces an acute profitability crisis.
Balance Sheet Quality: High Leverage and Liquidity Concerns
The balance sheet reveals a company operating with elevated leverage. Average net debt to equity stands at 1.60, indicating high dependence on borrowed funds relative to shareholder capital. Current liabilities surged to ₹12.10 crores as of March 2025 from just ₹0.62 crores in March 2024, a near 20-fold increase that significantly strains the company's financial flexibility. Current assets, meanwhile, declined to ₹0.76 crores from ₹2.06 crores over the same period, creating a severe current ratio imbalance and raising liquidity concerns.
The company maintains minimal fixed assets at ₹0.01 crores and reports zero investments as of March 2025, suggesting a business model focused primarily on lending activities. However, the sharp contraction in current assets alongside the explosion in current liabilities points to potential collection difficulties or asset quality issues. The cash flow statement for FY25 shows negative operating cash flow of ₹1.00 crores, with investing activities consuming ₹13.00 crores and financing activities providing ₹14.00 crores, indicating heavy reliance on external funding to sustain operations.
Industry Context: Struggling in a Competitive NBFC Landscape
The NBFC sector has witnessed significant consolidation and regulatory scrutiny in recent years, with smaller players finding it increasingly difficult to compete against well-capitalised peers. Shyamkamal Investments operates in the micro-cap segment with a market capitalisation of just ₹37.19 crores, placing it at a significant disadvantage in terms of funding costs, regulatory compliance capabilities, and operational scale. The company's 5-year sales growth of 157.00% and EBIT growth of 71.00% might appear impressive on paper, but these figures are distorted by an extremely low base and lack consistency.
The broader NBFC sector returned 6.54% over the past year, whilst Shyamkamal delivered 32.96%, outperforming its sector by 26.42 percentage points. However, this outperformance is largely technical in nature, driven by the stock's micro-cap status and low liquidity rather than fundamental strength. The company's institutional holding stands at zero, with no foreign institutional investors (FIIs), mutual funds, or insurance companies holding stakes, reflecting a complete absence of institutional confidence in the business.
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity | Div Yield (%) |
|---|---|---|---|---|---|
| Shyamkamal Inv | 21.37 | 5.08 | 2.42 | 1.60 | 0.36 |
| Sugal & Damani | 8.27 | 1.45 | 9.67 | 0.02 | — |
| Prism Medico | 67.59 | 2.73 | 0.59 | 0.00 | — |
| Anupam Finserv | 23.09 | 1.35 | 6.38 | 0.11 | — |
| JMJ Fintech | 5.80 | 1.08 | 11.50 | 0.00 | 2.03 |
| Glance Finance | 37.88 | 0.73 | 4.20 | 0.03 | — |
Relative to its peer group, Shyamkamal Investments exhibits several concerning characteristics. Its average ROE of 2.42% ranks at the bottom of the peer set, well below JMJ Fintech's 11.50% and Sugal & Damani's 9.67%. Despite this weak profitability, the stock trades at a price-to-book value of 5.08x, the highest amongst peers and difficult to justify given the underlying fundamentals. The debt-to-equity ratio of 1.60 is also the highest in the group, indicating aggressive leverage that amplifies both returns and risks.
Valuation Analysis: Expensive Despite Deteriorating Fundamentals
At ₹14.08 per share, Shyamkamal Investments trades at a price-to-earnings ratio of 21.37x based on trailing twelve-month earnings. Whilst this appears reasonable compared to the industry average P/E of 85x, the comparison is misleading given the company's recent quarterly loss and inconsistent earnings trajectory. The stock's price-to-book value of 5.08x represents a significant premium to book value of ₹5.56 per share, a valuation that appears unjustified given the negative reserves, weak ROE, and deteriorating operational performance.
The company's valuation grade currently stands at "EXPENSIVE", having oscillated between "Expensive", "Fair", and "Attractive" over recent months, reflecting the stock's volatile price movements rather than any fundamental improvement. Enterprise value metrics paint a similarly concerning picture, with EV/EBITDA at 19.42x and EV/Sales at 19.11x, both elevated multiples for a micro-cap NBFC with questionable earnings quality. The PEG ratio of 0.12x might suggest undervaluation relative to growth, but this metric is rendered meaningless by the erratic earnings pattern and recent quarterly loss.
The stock's 52-week range of ₹9.57 to ₹16.65 shows significant volatility, with the current price sitting 15.44% below the high and 47.13% above the low. The company declared a dividend of ₹0.10 per share with an ex-dividend date of November 26, 2025, yielding just 0.36% at current prices. Given the recent quarterly loss and weak cash generation, the sustainability of even this modest dividend appears questionable. Fair value estimation becomes challenging given the inconsistent earnings, but based on peer comparisons and fundamental analysis, the stock appears overvalued by approximately 25-30% at current levels.
Shareholding Pattern: Complete Absence of Institutional Support
The shareholding pattern reveals a dramatic shift in ownership structure and a complete absence of institutional confidence. Promoter holding stood at 1.59% in both June 2025 and March 2025 before declining to zero in September 2025 and remaining at that level through March 2026. This complete promoter exit raises significant red flags about insider confidence in the company's future prospects. When those closest to the business divest their entire holdings, it typically signals deep-seated concerns about viability or strategic direction.
| Quarter | Promoter % | QoQ Change | FII % | MF % | Insurance % | Non-Inst % |
|---|---|---|---|---|---|---|
| Mar'26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 |
| Dec'25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 |
| Sep'25 | 0.00 | -1.59 | 0.00 | 0.00 | 0.00 | 100.00 |
| Jun'25 | 1.59 | 0.00 | 0.00 | 0.00 | 0.00 | 98.41 |
| Mar'25 | 1.59 | — | 0.00 | 0.00 | 0.00 | 98.41 |
Non-institutional holdings now account for 100.00% of the shareholding, up from 98.41% in March 2025 following the promoter exit in September 2025. There are zero foreign institutional investors, zero mutual funds, and zero insurance companies holding stakes in the company. This complete absence of institutional participation is highly unusual even for micro-cap stocks and reflects the market's assessment of the company's risk-reward profile. Institutional investors typically conduct rigorous due diligence before investing, and their complete absence speaks volumes about the perceived quality and sustainability of Shyamkamal's business.
Stock Performance: Technical Strength Masking Fundamental Weakness
Despite the concerning fundamental deterioration, Shyamkamal Investments' stock has delivered impressive returns across multiple timeframes. The stock gained 32.96% over the past year, significantly outperforming the Sensex's -7.99% decline by a remarkable 40.95 percentage points of alpha. Over three years, the stock has surged 314.12% compared to the Sensex's 21.62% gain, generating 292.50 percentage points of alpha. Year-to-date, the stock is up 16.75% against the Sensex's -11.90% decline.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +2.85% | -0.43% | +3.28% |
| 1 Month | +7.48% | -5.29% | +12.77% |
| 3 Months | +11.30% | -9.34% | +20.64% |
| 6 Months | +8.39% | -11.92% | +20.31% |
| YTD | +16.75% | -11.90% | +28.65% |
| 1 Year | +32.96% | -7.99% | +40.95% |
| 3 Years | +314.12% | +21.62% | +292.50% |
However, these returns come with extreme volatility. The stock exhibits a beta of 1.50, indicating 50% higher volatility than the broader market, and is classified as a "HIGH RISK HIGH RETURN" investment with annualised volatility of 64.29%. The risk-adjusted return of 0.51 over one year, whilst positive, pales in comparison to the headline returns when volatility is factored in. Technical indicators currently show a "BULLISH" trend as of May 6, 2026, with the stock trading above all major moving averages (5-day, 20-day, 50-day, 100-day, and 200-day). However, this technical strength appears disconnected from the fundamental reality of deteriorating operations.
Investment Thesis: High Risk with Limited Fundamental Support
The investment case for Shyamkamal Investments faces severe challenges across multiple dimensions. The company's overall Mojo Score stands at just 36 out of 100, placing it firmly in "SELL" territory. This score reflects the confluence of negative factors including deteriorating financial trends, below-average quality metrics, expensive valuation, and high operational risks. The company previously held a "STRONG SELL" rating on April 17, 2026, at ₹13.09, before improving marginally to "SELL" on October 29, 2025.
The quality assessment reveals a "BELOW AVERAGE" grade, reflecting weak long-term financial performance despite healthy 5-year sales growth of 157.00%. The company's average ROE of 2.42% ranks amongst the lowest in its peer group, whilst high leverage (average net debt to equity of 1.60) amplifies financial risk. Zero institutional holdings underscore the market's lack of confidence in the business model. The financial trend is unequivocally "NEGATIVE" for Q4 FY26, with profit at ₹-0.49 crores having fallen 146.70%, PBDIT at the lowest level of ₹-0.22 crores, and earnings per share hitting a low of ₹-0.19.
Key Strengths & Risk Factors
Key Strengths
- Strong Historical Returns: 314.12% gain over three years demonstrates significant price appreciation potential in favourable market conditions
- Technical Momentum: Currently in bullish trend trading above all major moving averages, providing near-term technical support
- Sector Outperformance: 26.42 percentage points outperformance versus NBFC sector over past year
- Low Institutional Ownership: 100% non-institutional holding creates potential for discovery by institutional investors if fundamentals improve
- Micro-Cap Premium: Small size allows for significant percentage gains on relatively small capital inflows
Key Concerns
- Quarterly Loss: ₹0.49 crores loss in Q4 FY26 represents 146.67% YoY decline and 194.23% QoQ deterioration
- Negative Revenue: Net sales of ₹-0.10 crores indicates fundamental operational breakdown requiring immediate attention
- Complete Promoter Exit: Zero promoter holding as of September 2025 raises serious questions about insider confidence
- Weak Profitability: Average ROE of 2.42% ranks at bottom of peer group, indicating poor capital efficiency
- High Leverage: Debt-to-equity of 1.60 amplifies downside risks in deteriorating operating environment
- Liquidity Stress: Current liabilities of ₹12.10 crores versus current assets of ₹0.76 crores creates severe working capital pressure
- Zero Institutional Support: Complete absence of FII, MF, and insurance holdings reflects market scepticism
Outlook: Critical Monitoring Points Ahead
Positive Catalysts
- Return to positive revenue generation in upcoming quarters
- Successful resolution of asset quality issues driving negative sales
- Fresh capital infusion to address liquidity constraints
- New promoter or strategic investor entry providing governance stability
- Demonstrable improvement in ROE above 8-10% threshold
Red Flags to Watch
- Continued negative or declining revenues in Q1 FY27
- Further increase in current liabilities without corresponding asset growth
- Inability to service interest obligations leading to default risk
- Regulatory actions or compliance issues given NBFC status
- Stock price breakdown below ₹12.00 support levels
The path forward for Shyamkamal Investments requires immediate operational turnaround and strategic clarity. Investors should closely monitor Q1 FY27 results due in August 2026 for signs of revenue stabilisation and return to profitability. The company's ability to address its liquidity crisis, reduce leverage, and attract institutional or strategic investors will determine whether it can survive as a going concern. Given the severity of current challenges, any investment in this stock carries exceptionally high risk.
The Verdict: Avoid Until Fundamental Stability Returns
Score: 36/100
For Fresh Investors: Avoid initiating positions at current levels. The combination of negative revenue generation, quarterly losses, complete promoter exit, and severe liquidity constraints creates an unacceptable risk-reward profile. Wait for at least two consecutive quarters of positive revenue and profitability before considering entry.
For Existing Holders: Consider reducing positions on any technical rallies. The fundamental deterioration in Q4 FY26 represents a significant negative inflection point that cannot be ignored. Whilst the stock maintains technical strength, this appears disconnected from operational reality. Use any bounce towards ₹15.00-16.00 levels as exit opportunities to limit downside exposure.
Fair Value Estimate: ₹9.00-10.00 (36-29% downside from current levels), based on peer P/BV multiples of 1.5-2.0x applied to book value of ₹5.56, adjusted for below-average quality and negative earnings trajectory.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. The views expressed are based on data available as of May 21, 2026, and are subject to change. Past performance does not guarantee future results. Investing in micro-cap stocks carries substantial risks including illiquidity, volatility, and potential loss of capital.
